Over 67,000 cattle died so far from lumpy skin disease in India: Govt

Already, 1.5 crore goat pox doses have been given, he said.While only 1 ml dose of the goat pox vaccine is sufficient to help fight LSD in areas where no case has been reported, doses of 3 ml each can be administered in cattle where an outbreak has been reported, he added.With regard to the new vaccine, Swain said the commercial launch of Lumpi-ProVacInd would take the next three-four months. The manufacturers will have to take permission from the Drugs Controller General of India DCGI for commercial production of the new vaccine.

The Centre on Monday said over 67,000 cattle have died since the outbreak of the lumpy skin disease in July, prompting a massive effort to vaccinate cattle in over eight states with most cases of the disease.

Speaking to PTI, Animal Husbandry and Dairying Department Secretary Jatindra Nath Swain said states are currently using the 'goat pox' vaccine to control lumpy skin disease (LSD) in cattle.

The commercial launch of a new vaccine 'Lumpi-ProVacInd' for LSD, developed by two institutes of Agri research body ICAR, will take the next ''three-four months,'' he said.

The lumpy skin disease has spread mainly in Gujarat, Rajasthan, Punjab, Haryana, Uttar Pradesh, Uttarakhand, Madhya Pradesh, and Jammu & Kashmir. There are some stray cases in Andhra Pradesh and Andaman & Nicobar Islands.

''In Rajasthan, the number of death is 600-700 per day. But in other states, it is less than 100 in a single day,'' he said, adding that the ministry has asked states to accelerate the vaccination process.

According to Swain, the goat pox vaccine is ''100 percent effective'' and already 1.5 crore doses have been administered in the affected states.

He also said there is a sufficient supply of goat pox vaccine in the country. Two companies are manufacturing this vaccine and they can produce 4 crore doses a month.

The total cattle population is around 20 crore. Already, 1.5 crore goat pox doses have been given, he said.

While “only 1 ml dose” of the goat pox vaccine is sufficient to help fight LSD in areas where no case has been reported, doses of 3 ml each can be administered in cattle where an outbreak has been reported, he added.

About the new vaccine, Swain said the commercial launch of ''Lumpi-ProVacInd'' would take the next ''three-four months.'' ''The manufacturers will have to take permission from the Drugs Controller General of India (DCGI) for commercial production of the new vaccine. It will take the next 3-4 months for commercial launch,'' he added.

On the impact of LSD on milk production, the managing director of Gujarat Cooperative Milk Marketing Federation (GCMMF), which markets dairy products under the Amul brand, R S Sodhi said there has been a marginal impact of 0.5 percent on milk production in Gujarat.

The situation in Gujarat is under control because of the vaccination process, he added.

Sodhi said the impact could be a little higher in other states. ''The procurement of organized milk producers including Amul has gone down compared to the year-ago period. But this cannot be attributed to LSD. Unlike last year, unorganized players, sweet makers, and hotels are aggressively procuring milk,'' he said.

Mother Dairy MD Manish Bandlish said, ''There is a minor impact on production in the overall scheme of things.'' LSD entered India, Bangladesh, and China in July 2019. Lumpy skin disease (LSD) is a contagious viral disease that affects cattle and causes fever, and nodules on the skin, and can also lead to death. The disease gets spread by mosquitoes, flies, lice, and wasps by direct contact among the cattle, and through contaminated food and water.

India, the world's largest milk producer, had a cattle population of 192.5 million in 2019, as per the 19th Livestock census.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)